Assura (LON:AGR) Given “Hold” Rating at Peel Hunt

Share on StockTwits

Peel Hunt reaffirmed their hold rating on shares of Assura (LON:AGR) in a research note published on Tuesday, ThisIsMoney.Co.Uk reports.

Separately, Liberum Capital reiterated a hold rating on shares of Assura in a research note on Tuesday, July 2nd.

AGR opened at GBX 70.60 ($0.92) on Tuesday. The company has a quick ratio of 0.39, a current ratio of 0.73 and a debt-to-equity ratio of 53.61. Assura has a 52-week low of GBX 52.40 ($0.68) and a 52-week high of GBX 71.80 ($0.94). The company has a 50 day moving average of GBX 67.92 and a two-hundred day moving average of GBX 62.67. The company has a market cap of $1.70 billion and a P/E ratio of 20.17.

The firm also recently disclosed a dividend, which will be paid on Wednesday, October 16th. Shareholders of record on Thursday, September 12th will be paid a dividend of GBX 0.69 ($0.01) per share. The ex-dividend date of this dividend is Thursday, September 12th. This represents a yield of 0.97%. Assura’s dividend payout ratio is currently 0.86%.

In other news, insider Orla Ball sold 9,733 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of GBX 71 ($0.93), for a total value of £6,910.43 ($9,029.70). Also, insider Jonathan Murphy sold 102,907 shares of the company’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of GBX 65 ($0.85), for a total transaction of £66,889.55 ($87,403.04).

Assura Company Profile

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high-quality patient care in the community.

Featured Story: Is it Safe to Invest in Commodities?

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.